GlaxoSmithKline Pakistan Limited (GLAXO) announcements
Everything GlaxoSmithKline Pakistan Limited has filed with the Pakistan Stock Exchange, newest first: financial results, insider trades, material information and notices.
- NoticeTransmission of Quarterly Report for the Period Ended September 30, 2026
- Financial resultGlaxoSmithKline Pakistan Limited reported a revenue of Rs 48.11 billion for the nine months ended September 30, 2026Filed as: Financial Results for the Quarter Ended September 30, 2026
- NoticeBoard Meeting Quarter 3-2026
- NoticeShariah Disclosure for the Half Year ended June 30, 2026
- NoticeCredit of Interim Cash Dividend
- NoticeAppointment of Chief Financial Officer
- NoticeAppointment of Executive Director
- NoticeNotice of interim cash dividend and share book closure
- NoticeTransmission of Quarterly Report for the Period ended June 30, 2026
- NoticePrior Publication of Notice of Interim Cash Dividend and Share Book Closure
- NoticeChange in Book Closure Date
- Financial resultGlaxoSmithKline Pakistan Limited reported a revenue of Rs 31.52 billion for the half year ended June 30, 2026Filed as: Financial Results for the Quarter Ended June 30, 2026
- NoticeBoard Meeting
- NoticeAppointment of Interim/ Acting Chief Financial Officer
- NoticeAppointment of Non-Executive Director
- NoticeResignation of Chief Financial Officer & Executive Director
- NoticeResignation of Non-Executive Director
- Notice(Re) Appointment of Chairperson and Chief Executive Officer
- Financial resultGlaxoSmithKline Pakistan Limited reported a strong performance for the quarter ended March 31, 2026Filed as: Financial Results for the Quarter Ended March 31, 2026
- Material informationChairperson Resignation AnnouncedMs. Lai Kuen Goh resigns as Chairperson and Non-Executive Director of GSK Pakistan effective March 31, 2026.
- Financial resultGlaxoSmithKline Pakistan Limited reported a strong financial performance for the year ended December 31, 2025Filed as: Financial Results for the year Ended 2025-12-31
Showing the latest 21. Source: company filings on the Pakistan Stock Exchange. Summaries are written from the filings by software and can contain errors; the filing itself is the record. Investing in securities involves risk, including possible loss of principal.